Senior Platform Engineer, Genesis Therapeutics

Salary not provided

AWS

Kubernetes

Python

Bash

Terraform

Mid and Senior level

San Francisco Bay Area

2+ days a week in office (Burlingame, CA)

Unifying AI and biotechnology for drug discovery

Job no longer available

Unifying AI and biotechnology for drug discovery

21-100 employees

HealthcareB2BArtificial IntelligenceDeep TechBiologyMachine LearningScienceMedTech

Job no longer available

Salary not provided

AWS

Kubernetes

Python

Bash

Terraform

Mid and Senior level

San Francisco Bay Area

2+ days a week in office (Burlingame, CA)

21-100 employees

HealthcareB2BArtificial IntelligenceDeep TechBiologyMachine LearningScienceMedTech

Company mission

To transform small molecule drug discovery to solve critical patient needs.

Job

Company

Role

Who you are

3+ years of experience creating and maintaining infrastructure at scale, on top of AWS or Google Cloud
Proficient in Python, Bash, and preferably Terraform
A responsible and tenacious engineer who loves to architect secure, scalable systems and dive deep to solve obscure issues

What the job involves

Improve our job scheduling and workflow management system called Flow, written in Python on top of Kubernetes, to manage our cluster of 1,000s of GPUs and 10,000s of CPUs
Help maintain our production infrastructure within Google Cloud, refining our scripts and procedures for testing, monitoring, and deployment automation
Work closely with our machine learning engineers and computational chemists to optimize our infrastructure for both research throughput and production robustness

Our take

Genesis Therapeutics is at the forefront of advancing drug creation to foster better healthcare outcomes. the company offers an AI-powered molecule discovery platform, known as GEMS, designed to empower medical researchers. By seamlessly integrating AI with biotech, GEMS leverages deep learning and molecular simulations to explore uncharted territories within chemical space, unveiling novel opportunities for functional drugs.

Boasted to be the "industry's most advanced molecular AI platform", GEMS accelerates the discovery of small molecules while also enhancing potency and selectivity. This breakthrough capability not only expedites the development process but also paves the way for creating medications targeting previously inaccessible domains.

With significant funding backing its endeavours, Genesis Therapeutics is poised to transition into clinical testing. Moreover, the company aims to broaden the scope of its platform, extending its reach to encompass a wider array of therapeutic targets.

Kirsty

Company Specialist at Welcome to the Jungle

Company

Funding (last 2 of 3 rounds)

Aug 2023

$224.1m

SERIES B

Dec 2020

$52m

SERIES A

Total funding: $280.2m

Company benefits

Stock Option Eligibility
401(k) Plan
Open PTO Policy
Paid Company Holidays
Free lunch and snacks at our offices
Health Care Plan, including Medical, Dental, and Vision, fully covered for the employees

Company HQ

Country Club Manor, Hillsborough, CA

Leadership

Evan Feinberg

(CEO & Co-Founder)

PhD Graduate from Stanford, where they were an Algorithm Developer, collaborating with the Office of Technology Licensing to develop BraneRank (which uses graph substructures to rank search results). Was then a Deep Learning Consultant for Merck for 11 months.

Ben Sklaroff

(CTO & Co-Founder)

Graduated from UC Berkeley with a degree in Electrical Engineering and Computer Science. Worked at Markforged for 3 years, ultimately as Director of Software Engineering.

Salary benchmarks

We don't have enough data yet to provide salary benchmarks for this role.

Submit your salary to help other candidates with crowdsourced salary estimates.

Share this job